RJFSA
RXST icon

Raymond James Financial Services Advisors’s RxSight RXST Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-83,920
Closed -$5.05M – 3543
2024
Q2 		$5.05M Buy
+83,920
New +$4.8M 0.01% 1162

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's RXST Position: Q3 2024 in Review

Raymond James Financial Services Advisors sold out of RxSight (RXST) in Q3 2024, closing a stake of 83,920 shares — an estimated $5.05M sold.

Raymond James Financial Services Advisors first reported a position in RXST in Q2 2024 and held it in 1 quarter. The position peaked at $5.05M in Q2 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • Raymond James Financial Services Advisors reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 83,920 RxSight shares in Q3 2024, an estimated $5.05M.
  • Raymond James Financial Services Advisors first reported a position in RxSight in Q2 2024 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's RxSight position peaked at $5.05M in Q2 2024.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.